Genentech

E7901

Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.

Aliases (2)

Statements (49)
Predicate Object
instanceOf biotechnology company
pharmaceutical company
subsidiary
acquiredBy Roche
acquisitionDate 2009
appliesMethod genetic engineering
collaboratedWith Eli Lilly and Company
country United States
develops biologic therapies
protein-based drugs
therapeutic antibodies
focusesOn immunology
neuroscience
oncology
ophthalmology
formerListedCompany true
foundedBy Herbert Boyer
Robert Swanson
foundedIn San Francisco Bay Area
foundingDate 1976
hasMajorTherapeuticArea autoimmune diseases
cancer
cardiovascular disease
hasMotto Doing now what patients need next
hasResearchCenter South San Francisco
headquartersLocation South San Francisco, California
industry biotechnology
pharmaceuticals
knownFor monoclonal antibody therapies
recombinant DNA–based medicines
legalForm corporation
locatedInTheAdministrativeTerritorialEntity California
notableFor being one of the first companies to commercialize recombinant human insulin
notableProduct Activase
Avastin
Herceptin
Lucentis
Perjeta
Rituxan
Tecentriq
Xolair
numberOfEmployees over 10000
operatesIn biopharmaceutical research and development
parentOrganization Roche
partOf Roche Group
stockExchange New York Stock Exchange
subsidiaryOf Roche
tickerSymbol DNA
website https://www.gene.com


Please wait…